Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Rx Reforms: No Automatic “Controversy” For Declaratory Judgments

Executive Summary

The Medicare conference bill's Waxman/Hatch reform provisions would require federal courts to determine whether declaratory judgment actions brought by ANDA filers against innovators are a "case or controversy" under the Constitution

You may also be interested in...



Declaratory Judgment Ruling Will Add Uncertainty To Generic Launches

Generic companies are likely to face an increased threat of patent infringement lawsuits on the eve of launch following an appeals court ruling on the standards for seeking a declaratory judgment of noninfringement

Declaratory Judgment Ruling Will Add Uncertainty To Generic Launches

Generic companies are likely to face an increased threat of patent infringement lawsuits on the eve of launch following an appeals court ruling on the standards for seeking a declaratory judgment of noninfringement

Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt

The generic industry is facing a "downturn" in the market for products with low barriers to entry, Sandoz CEO Andreas Rummelt said Jan. 20

Related Content

UsernamePublicRestriction

Register

PS042870

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel